A UK biotech start-up has secured $14mn in early-stage funding led by MSD Global Health Innovation Fund to develop vaccines that are “future-proofed” by artificial intelligence.
英国一家生物技术初创企业获得了由默沙东manbetx app苹果 健康创新基金(MSD GHIF)领投的1400万美元早期融资，用于开发人工智能“经得起未来考验”的疫苗。
您已阅读9%（391字），剩余91%（4073字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。